0000899243-18-021374.txt : 20180803
0000899243-18-021374.hdr.sgml : 20180803
20180803160655
ACCESSION NUMBER: 0000899243-18-021374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180801
FILED AS OF DATE: 20180803
DATE AS OF CHANGE: 20180803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Price David
CENTRAL INDEX KEY: 0001449336
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 18991865
MAIL ADDRESS:
STREET 1: C/O CORNERSTONE THERAPEUTICS INC
STREET 2: 1255 CRESCENT GREEN DRIVE SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-01
0
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001449336
Price David
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
0
1
0
0
Chief Financial Officer
Employee Stock Option (right to buy)
2.22
2018-08-01
4
A
0
385000
0.00
A
2028-08-01
Common Stock
385000
385000
D
The option to purchase will vest and become exercisable in three equal annual installments beginning August 1, 2019.
/s/ John Mercer, Attorney-in-Fact
2018-08-03